Patent Assignment
Reel/Frame 048168/0423
Assignment of Assignor's Interest
Recorded: 2019-01-29
Pages: 3
Assignor
BORTEY, ENOCH
Executed: 2014-01-27
Assignee
SALIX PHARMACEUTICALS, LTD.
8510 COLONNADE CENTER DRIVE, RALEIGH, NORTH CAROLINA, 27615
Covered Property
(1)
Methods for Treatment and Prevention of Opioid Induced Constipation Using Oral Compositions of Methylnaltrexone
Application:
16/206,570 →
Publication:
US 2019/0231771
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement
Mar 27, 2019
From: BAUSCH & LOMB INCORPORATED; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 048715/0406 →
Intellectual Property Security Agreement
Mar 27, 2019
From: BAUSCH & LOMB INCORPORATED; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048715/0432 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →